
Read via bit.ly/4zs86Fe "Review Article: Cirrhosis Recompensation- Definition, Natural History, Clinical Implications and Considerations for Clinical Trials" #livertwitter #cirrhosis #clinicaltrials

@APandT new papers in AP&T, summaries free-to-view. 2023 Impact Factor is 6.6, ranking AP&T 18/97 for journals in Gastroenterology & Hepatology.

Read via bit.ly/4zs86Fe "Review Article: Cirrhosis Recompensation- Definition, Natural History, Clinical Implications and Considerations for Clinical Trials" #livertwitter #cirrhosis #clinicaltrials

"Carbon Footprint of Diagnostic Modalities Used in Inflammatory Bowel Disease Care: The EVERGREEN-IBD Study" available to read at bit.ly/3V3Ial8 #IBD #GItwitter

Read open access via bit.ly/4eiZRnl "Development of a Clinical and Biomarker-Based Score to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea" #GItwitter #colitis #diarrhoea

Available to read 'open access' via bit.ly/4igTljq "Clinical Trial: Capsule Sponge as a Non-Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study" #GItwitter #EoE

"Management and Outcomes of Bleeding Ectopic Varices in Patients With Liver Cirrhosis: A Systematic Review and Pooled Analysis" published at bit.ly/3UVbURd #livertwitter #varices #cirrhosis

Read open access via bit.ly/4kjDm5o "Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients" #GItwitter #diarrhoea #colon

"Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease" avaible to read via bit.ly/4A1s0I7 #GItwitter #IBD #infliximab

Read open access via bit.ly/3UinXro "Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non-Anticoagulated Patients". #GItwitter #GIbleeding

"Incidence and Risk Factors for C. difficile Reinfection After Faecal Microbiota Transplantation or Antibiotic Therapy" by Kelly CR et al is available to read at bit.ly/4i0QDhY #GItwitter #microbiota #CDI #FMT

Read open access via bit.ly/4izC5WE "Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study" #GItwitter #oesophagus #GIcancer

Read open access via bit.ly/4jNVap6 "Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease" #GItwitter #IBD #surgery

"Clinical Trial: Dupilumab Improves Eosinophilic Oesophagitis Outcomes Versus Placebo Regardless of Comorbidities or Treatment History in a Randomised Clinical Trial" is available to read open access via bit.ly/4hMiVeJ #EoE #GItwitter

Read via bit.ly/4dAYKiH "Systematic Review: Inclusion of Patients With Difficult-to-Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies" #GItwitter #IBD

Read via bit.ly/4hwAKOB "Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity" #livertwitter #PSC #PBC

"Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection" - read via bit.ly/4hUyvWK #HBV #livertwitter #HCC

"Revisiting Ferritin-IgG Score to Predict Complete Biochemical Response in Autoimmune Hepatitis" is available to read open access via bit.ly/3Vi8KXH #livertwitter #AIH